The policy authorizes disclosure of personal information to third parties in connection with proposed or actual mergers, acquisitions, consolidations, asset sales, bankruptcies, and other corporate transactions. This authorization applies to proposed as well as completed transactions.
This analysis describes what Oscar Health's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision authorizes pre-transaction disclosure of personal information to potential acquirers or transaction counterparties before any transaction is completed, which means personal data may be disclosed to third parties who ultimately do not complete a transaction with Oscar.
Under this provision, personal information including identifiers, health-adjacent data, and financial information may be disclosed to counterparties in connection with a proposed corporate transaction, including transactions that are not ultimately completed. No user notification or opt-out mechanism is described for this disclosure category.
Cross-platform context
See how other platforms handle Corporate Transaction Disclosure and similar clauses.
Compare across platforms →"Corporate Transactions: We may disclose your Personal Information in connection with a proposed or actual corporate merger, acquisition, consolidation, sale of assets, bankruptcy, insolvency, or other corporate change... Support Business Transfers. To implement mergers, acquisitions, reorganizations, and other business transactions, and where necessary to the administration of our general business, accounting, recordkeeping, and legal functions.Excerpt from Oscar Health's Privacy Policy
1) REGULATORY LANDSCAPE: This provision implicates FTC guidance on data transfer in corporate transactions, particularly in contexts where the acquiring entity may operate under materially different privacy practices.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision authorizes pre-transaction disclosure of personal information to potential acquirers or transaction counterparties before any transaction is completed, which means personal data may be disclosed to third parties who ultimately do not complete a transaction with Oscar.
Under this provision, personal information including identifiers, health-adjacent data, and financial information may be disclosed to counterparties in connection with a proposed corporate transaction, including transactions that are not ultimately completed. No user notification or opt-out mechanism is described for this disclosure category.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Oscar Health.